Background. Bone metabolism is a complex system, and fracture healing is one of its most important functions. Many circumstances can influence this process. Chronic drug use in elderly populations can affect bone healing, and inadequate tissue perfusion, increased free radicals and adverse drug effects can negatively influence fracture healing. Nebivolol, an anti-hypertensive drug that selectively blocks β1 receptors, effectively reduces blood pressure by inducing peripheral vasodilation. Nebivolol also exerts anti-oxidant effects by stimulating nitric oxide (NO) synthesis. Many studies show that NO protects the vascular endothelium and improves fracture healing.
Fracture healing is a complex process that requires a local hematoma rich in mesenchymal cells and cytokines. In the fracture healing phase, there is a strong correlation between angiogenesis and osteogenesis. Transportation of biomaterials through the blood to the fracture site is necessary for adequate and prompt healing. The process of converting the organized hematoma to bone callus includes endochondral and intramembranous ossification stages. In addition, chondrocyte differentiation and mineralization require adequate nutrition from the vascular bed. [1] [2] [3] Nebivolol is a highly selective β 1-adrenergic receptor antagonist that is used for antihypertensive therapy. 4 In many individuals, a dose of 5 mg effectively reduces blood pressure over a 24 h period and has been shown to cause endothelium-dependent vasodilation. 5, 6 Nebivolol demonstrates systemic anti-oxidant effects by stimulating nitric oxide (NO) release. 7 NO is produced by endothelial NO synthase (eNOS) from L-arginine. 6, 8 The l-nebivolol enantiomer stimulates NO release, and the d-nebivolol enantiomer is responsible for a β1-selective blockade.
The aim of this study was to evaluate the effect of intraperitoneally administered nebivolol on fracture healing. Histological and radiological evaluation of healing was performed in nebivolol and control groups using a rat open femoral fracture model.
Material and methods
Twenty-one adult Sprague Dawley rats (average weight 250 g) were used in this study. All in vivo study protocols were approved by the Institutional Laboratory Animal Care and Use Ethical Committee. The animals were housed in the Laboratory Animal Care-Augmentation Facility of Dumlupınar University in a temperaturecontrolled room (room temperature 20-22°C) on a 12 h light-dark cycle and were provided with rat pellets with water ad libitum. There were 7 animals in each standard cage.
Nebivolol preparation
Five-milligram nebivolol tablets (Vasoxen, Menarini Group, I. E. Ulagay, Germany) were pulverized and dissolved in distilled water to obtain a 0.017 mg/mL solution. This was equivalent to a 5 mg adult human (70 kg) dose.
Surgical procedure
The 21 rats were randomly divided into 3 groups: nebivolol 1, nebivolol 2, and the control. Following the induction of anesthesia with intraperitoneal injection of ketamine (50 mg/kg) and xylazine hydrochloride (10 mg/kg), the right hind limb of each animal was shaved and prepared with chlorhexidine gluconate for aseptic surgery. Using an aseptic technique, a longitudinal incision was made on the lateral aspect of the right hind limb. An open femoral fracture was created on the midshaft of the femur using a 1.0 mm sterile drill (Aysam Samsun, Turkey). Two perpendicular drill holes were made in the middle of the shaft, and the bone was manually broken. An intramedullary fixation was performed using a 1.50 mm (0.057 inch)-diameter stainless Kirschner wire (Aysam Samsun, Turkey). The wound was closed using 5-0 vicryl sutures (Pegelac, Doğsan Trabzon, Turkey), and the skin was closed with polypropylene 4-0 sutures (Propylene, Doğsan Trabzon, Turkey). The rats were left without cast immobilization for 4 weeks (Fig. 1 ).
Nebivolol treatment
Sterile nebivolol solution (1 mL) was given to the rats in group 1 every day for 4 weeks, while the rats in nebivolol group 2 were given 2 mL per day. At the end of the 4 th week, all rats were sacrificed, and the broken femurs were removed. Radiological examinations were first performed before fixing the femurs for 2 days in 10% buffered formaldehyde solution for histological examination.
Histological and immunohistochemical examination
The specimens were decalcified before embedding in paraffin. They were then sectioned (4 μm), placed on slides, and stained with hematoxylin & eosin (H&E) and Masson's trichrome. CD34 immunostaining was used to detect angiogenesis. Each specimen was graded based on 10 sections. Grades were determined based on the visual field. Slides were examined using a light microscope (Olympus BX51, Tokyo, Japan) for fracture healing and new bone formation by pathologists who were blinded to the groups. The histological assessment scale ( Table 1) described by Allen et al. was used for this study. 
Radiological examination
Standard anteroposterior roentgenograms were taken. An orthopedic surgeon evaluated the radiographic data according to the scale. Fracture healing was radiographically evaluated and graded into Class 0 (non-union), Class I (mild union), and Class II (union) groups.
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Statistical analysis
Radiologic and histologic scores were determined at the end of the 4 th week. Statistical analyses were performed using GraphPad Prism v. 6.05 (GraphPad Software, Inc., La Jolla, USA). All data was expressed as mean ± standard deviation (SD). Because of the small experimental groups, we used nonparametric statistical tests. The differences among the multiple groups were analyzed with the Kruskal-Wallis test. The differences between 2 groups were analyzed with Dunn's post-hoc test. A p-value < 0.05 was considered as statistically significant.
Results
All rats completed the 4-week study. K-wire migration was detected in the abdominal region of one rat in nebivolol group 1; the rat was not excluded from the study because it had no negative impact on animal welfare. The histological findings are shown in Fig. 2-4 .
Histological findings
The average histological scores for the control (Fig. 2) , and nebivolol groups 1 and 2 (Table 2) were 1.71, 2.28, and 2.85, respectively. Histopathological scoring results revealed that statistically significant differences were observed between the study groups (p = 0.007), as well as between nebivolol groups 1 and 2 (p < 0.005). Vascularity (red arrows) was remarkable in nebivolol group 2 (Fig. 4) . Trabecular bone formation was significant in nebivolol groups 1 and 2 (Fig. 3, 4) . Cartilage formation occurred at a higher rate in the control group (yellow arrow), compared with the nebivolol groups (Fig. 2) . 
Radiological findings
The average radiological scores were 1.14, 1.28, and 1.71 in the control and nebivolol groups 1 and 2, respectively. There were no statistically significant differences in radiographic results between the 3 groups and 2 groups (Fig. 5) .
Discussion
Hypertension and osteoporosis that results in poorly healing fractures are frequently seen in elderly populations. In addition, elderly populations typically have higher and more continuous drug use, due to the presence of chronic conditions. Chronic drug use can positively or negatively affect bone metabolism. Heparin and its derivatives have negative effects on the bone microstructure, while angiotensin-converting enzyme inhibitors can reduce fracture risk. 11, 12 The selective β1-blocker nebivolol, which is frequently used for hypertension, has both vasodilation and anti-oxidation effects. Recent studies suggest that high concentrations of nebivolol result in healing through the increased release of NO. 13 Gülcan et al. and Schaffer et al. previously showed that nebivolol had positive effects on wound healing. 14, 15 However, according to our knowledge, this study is the first to investigate the effects of nebivolol on fracture healing. Data are presented as mean ± standard deviation (SD); data were tested using the Kruskal-Wallis test and the Dunn's method was used for post hoc testing; p-value < 0.05 was considered statistically significant; p a < 0.05, compared to the control group.
The histochemical results of this study clearly show the positive effects of nebivolol on fracture healing. Complete bone union and trabecular bone formation were significantly higher in nebivolol group 2 (0.007) (Fig. 4 ). There were significant differences between the 5 mg/kg (nebivolol 1) treatment and the 10 mg/kg (nebivolol 2) treatment groups (p < 0.005). This suggests that nebivolol has a dose-dependent effect on healing. β1-receptors cause vascular endothelial injury, and nebivolol protects endothelial cells exerting anti-oxidative effects and prevents atherosclerosis. 16 However, nebivolol can also prevent osteoporosis by selectively inhibiting sympathetic nervous system β1 adrenergic receptors. 17 Nebivolol inhibits NO synthase uncoupling and produces systemic antioxidant effects. Thus, the beneficial activity of nebivolol is attributed to both the inhibition of eNOS uncoupling and endogenous antioxidant properties that lead to free-radical scavenging. 6, 18 Interestingly, nebivolol is the only selective β1-blocker that has anti-oxidative properties. 16 Turner et al. showed that treatment with an NOS inhibitor decreased new bone formation in a rat tibia model. 19 In addition, supplementation with NO induces new bone formation, and NO-mediated vasodilation increases blood flow during the early phases of fracture healing. 7, 20 There was no significant difference in radiographic results; however, nebivolol has a significantly positive effect on bone microstructure healing by inducing NO release. Therefore, the histological results obtained in this study could not be confirmed radiologically.
The results of this study suggest that nebivolol has positive effects on bone healing and thus can be used to treat hypertension in elderly populations. The limitations of the present study include the small sample size, which was a result of ethical considerations. In addition, bone healing was not determined through micro-computed tomography or positron emission tomography due to cost restrictions. These additional tests may demonstrate the vasodilatory effects of nebivolol for further support of our findings.
Conclusions
This study suggests that nebivolol, a selective β blocker, has positive effects on fracture healing through anti-oxidative effects via the NO pathway and direct vasodilator effects.
